REVB (STOCKS)
Revelation Biosciences, Inc. Common Stock
$1.110000
+0.000000 (+0.00%)
Prev close: $1.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- James M. Rolke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.81M
- Employees
- 9
- P/E (TTM)
- -0.09
- P/B (TTM)
- 0.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $82.16K |
| Nonoperating Income/Loss | $518.72K |
| Operating Expenses | $11.27M |
| Research and Development | $5.18M |
| Other Operating Expenses | $6.09M |
| Operating Income/Loss | -$11.27M |
| Income/Loss From Continuing Operations After Tax | -$10.75M |
| Income/Loss From Continuing Operations Before Tax | -$7.35M |
| Net Income/Loss | -$10.75M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.75M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $2.77M |
| Preferred Stock Dividends And Other Adjustments | $2.77M |
| Basic Earnings Per Share | -$19.54 |
| Diluted Earnings Per Share | -$19.37 |
| Basic Average Shares | 9,037,030 |
| Diluted Average Shares | 5,520,206 |
| Assets | $12.50M |
| Current Assets | $11.68M |
| Noncurrent Assets | $813.42K |
| Fixed Assets | $172.03K |
| Other Non-current Assets | $641.38K |
| Liabilities | $2.43M |
| Current Liabilities | $1.88M |
| Accounts Payable | $931.09K |
| Other Current Liabilities | $949.31K |
| Noncurrent Liabilities | $550.55K |
| Equity | $10.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.07M |
| Liabilities And Equity | $12.50M |
| Net Cash Flow From Operating Activities | -$9.33M |
| Net Cash Flow From Operating Activities, Continuing | -$9.33M |
| Net Cash Flow From Investing Activities | -$5.64M |
| Net Cash Flow From Investing Activities, Continuing | -$5.64M |
| Net Cash Flow From Financing Activities | $15.75M |
| Net Cash Flow From Financing Activities, Continuing | $15.75M |
| Net Cash Flow | $782.46K |
| Net Cash Flow, Continuing | $782.46K |
| Comprehensive Income/Loss | -$10.75M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.75M |
| Other Comprehensive Income/Loss | $0.00 |